Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.
Published January 22, 2020 · Recall initiated: December 2, 2019
Summary
FDA records drug Class III recall D-0789-2020, published January 22, 2020 and initiated December 2, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 100,080 bottles; Lot: Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
What to do
Voluntary: Firm initiated · Letter
Get an email if MOXIFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MOXIFLOXACIN
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Nationwide in the U.S.
- UPC
- 0365862840035
- Lot
- Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMoxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: AurobindoFebruary 23, 2022
- FDATestosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40)January 22, 2020
- FDATri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250January 22, 2020
- FDATestosterone Cypionate for Injection, USP, 1,000 mg/10 mL (100 mg/mL), 10 mL Multiple Dose Vial (NDCJanuary 22, 2020
- FDALipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 mL (40 mg/mL) Sterile 30 mLJanuary 22, 2020
- FDAMoxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc.August 8, 2018
Questions about this recall
Was Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03. recalled?
Yes. FDA published recall D-0789-2020 on January 22, 2020. Reported hazard: Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MOXIFLOXACIN. UPC: 0365862840035.